Abstract The large molecular size of antibodies is considered one major factor preventing them from becoming more efficient therapeutically. It is well established that all camelids have unique antibodies circulating in their blood called heavy-chain antibodies (HcAbs). Unlike antibodies from other species, these HcAbs contain a single variable domain and two constant domains (CH2 and CH3). HcAbs are a novel type of immunoglobulin-like, antigen binding protein with beneficial pharmacokinetic properties that are ideally suited to targeting cellular antigens for molecular imaging or therapeutic purposes. Since the antigen-binding site of dromedary HcAb is comprised in one single domain, it was referred to as nanobody. In the present work, the different IgG subclasses from immunized camel (Camelus dromedairus) were purified employing their different affinity for protein A column (PA) and protein G column (PG). Characterization of IgG subclasses was done by using 12% SDS-PAGE under reducing conditions. Protein bands were visualized after staining with Coomassie Brilliant Blue, showing two bands at 50 kDa and 30 kDa in case of IgG1 while IgG2 and IgG3 produce only one band at 46 kDa and 43 kDa respectively. The induction of apoptosis by either conventional or nanobodies was evaluated on two different cell lines, Colon and Hepatic cancer cell (HCT116 and HepG2), using the comet assay. Induced apoptosis were confirmed by visualizing DNA fragmentation bands on 2% agarose gel, and the gel was photographed under UV light. This study demonstrates the successful targeting of human cancer colon cell lines by
nanobodies in vitro. It may open perspectives for their future use as tumor target vehicle, due to their small size, soluble behavior and they interact with epitopes that are less antigenic for conventional antibodies.
Introduction
Antibodies are composed of two identical heavy-chains and two identical light-chains. The IgG from species of camelidae (Camelus and llama) forms a surprising exception to this paradigm as their serum contains also a considerable fraction of heavy-chain antibodies (HcAbs) that lack the L-chain. These HcAbs constitute approximately 50% of IgG in llama serum and as much as 75% of IgG in camel serum (Hamers-Casterman et al., 1993) . A nanobody is smaller than a single-chain Fv fragment, because it lacks both the light chain and the linker, whereas it has a similar affinity as variable regions of conventional antibodies (Pragnesh et al., 2010) .
During the last decade, the U.S. Food and Drug Administration have approved 21 mAbs for therapy, mostly for the systemic treatment of cancer. These mAbs are used to completely neutralize/block growth factors or growth factor receptors, the key drivers of tumor growth and survival for a prolonged period (Khalissa et al., 2009) .
Several characteristics make nanobody use superior to the conventional antibodies. They are non-immunogenic and show high thermal and chemical stability (Cortez-Retamozo et al., 2002) . In addition, it does not show aggregations problems like single chain Fv because of hydrophilic instead of hydrophobic patches in the VH and VL domains. Nanobodies show a high solubility and a good capacity to refold after denaturation while retaining their binding capacity. There are several reports of raising specific nanobodies against enzymes, haptens, pathogens, toxins and tumor markers. All these characteristics make them strong candidates as targeting agents for cancer therapy (Khalissa et al., 2009) .
Colorectal cancers (CRC) are referred to colon and rectal cancers together. It causes 655,000 deaths worldwide annually. The incidence is slightly higher in men than women. The incidence of colorectal cancer is highest in developed countries such as the United States and Japan and lowest in developing countries such as Africa and Asia (Wakai et al., 2006) . CRC represents 8.5% of all tumors in Saudi Arabia as reported from studies published in the literature in the past 30 years (Abdulrahman, 2007) .
Hepatocellular carcinoma (HCC) is a primary malignancy of the liver. Most cases of HCC are secondary to either a viral hepatitis infection (hepatitis B or C) or cirrhosis (Kumar et al., 2003) . HCC, like any other cancer, develops when there is a mutation to the cellular machinery that causes the cell to replicate at a higher rate and/or results in the cell avoiding apoptosis (Chien et al., 2006) .
Many antitumor agents, have been reported to induce an apoptotic type of death in susceptible cells, thus apoptosis in tumor cells plays a critical role in killing tumor cells during cancer therapy (Zahri et al., 2009) .
Commonly used techniques for the estimation of apoptosis are comet assay and DNA fragmentation assay (Narendra, 2000) . The comet is a rapid and sensitive method for the detection of DNA damage in individual cells, induced by a variety of genotoxic agents. It was first introduced by Ö stling and Johanson (1984) , and later modified independently by Singh et al. (1988) and Olive (1989) . Image analysis provides three important parameters for each comet: tail length, tail fluorescence intensity and tail moment (Collins et al., 1997) . There has been increasing interest in the comet assay as the method used in various in vitro as well as in vivo studies to evaluate DNA damage and repair.
In this study, the aim was to compare the apoptotic effect of nanobodies (IgG2 and IgG3) and conventional antibodies (IgG1) on two different cancer cell lines (Human colon cancer and Human hepatic carcinoma). The camel IgGs were fractionated into its various subclasses by affinity chromatography and the apoptotic effects were estimated by using comet assay and DNA fragmentation methods.
Materials and methods

Dromedary immunization
An adult male dromedary (Camelus dromedarius) reared in the Camel Breeding Farm of the Ministry of Agriculture (Saudi Kingdom) was immunized for induction of antibodies and nanobodies. A camel was injected subcutaneously with 100, 75, 75, 50 and 50 lg EGFRvIII-ECD on days 1, 21, 36, 50 and 64, respectively according to Ghahroudi et al. (1997) . Complete Freund's adjuvant was used for the primary immunization (Sigma, St. Louis, MO), incomplete Freund's adjuvant for immunization 2-4 (Sigma, St. Louis, MO), and no adjuvant for the final immunization. The camel was bled one week following each immunization and the blood was collected aseptically in sterile containers containing heparin as anticoagulant, and then stored at -80°C until further use. Procedures for production and purification of extracellular domains of EGFR were performed in The Animal Reproduction Research Institute, Egypt according to Brown et al. (1994) . The protocol of this study was carried out according to the regulations and recommendation of the Animal Research Ethics Committee of College of Pharmacy, KSU, SA.
Separation of the IgG subclasses
IgG subclass was fractionated by a combination of affinity chromatography on PG and PA columns. Final protein concentration of the isolated serum fractions was determined by the Bradford method (Bio-Rad. Hercules, CA, and USA) and protein purity was assayed by 12% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) under reducing condition as described previously by Shaker (2010).
Cell culture and treatments
The cell lines HCT116 and HepG2 were obtained from the Department of Life Science and Biotechnology, Faculty of Chemistry, Material and Bioengineering, Kansai University, Japan. The cell lines were grown in the culture medium consisted of Weymouth MB 752 medium (Gibco) containing 10-15% fetal calf serum and supplemented with 300 lg/ml ascorbic acid (Sigma), 30 lg/ml hydrocortisone-21-sodium succinate (Sigma), 45 lg/ml ferrous sulfate, 100 units/ml penicillin/streptomycin solution (Gibco) and 100 units/ml mycostatin suspension (Gibco). The pH of the medium was checked and adjusted to 7.4 before filter sterilization (Millipore Millex). The gas phase consisted of 95% oxygen and 5% carbon dioxide for 48 h (Hodges and Melicher, 1976) .
Comet assay (SCGE)
The comet assay was performed in concordance with the premises established by Singh et al. (1988) with some modifications. Briefly, after 24 h of exposure of HCT116 and HepG2 cells to the tested substance in different Petri-dishes (60 · 15 mm, Greiner), the cells were trypsinized (0.1% for 4 min), suspended, homogenized in 1 ml of medium and centrifuged (10 min at 800 rpm). Subsequently 600 ll of Low Melting Agarose (0.8% in PBS) was added to the cell suspension (100 ll). Then 100 ll of this mixture was transferred to agarose pre-coated slides. The coated slides were immersed in lyses buffer (0.045 M TBE, pH 8.4, containing 2.5% SDS) for 15 min. The slides were placed in electrophoresis chamber containing the same TBE buffer, but devoid of SDS. The electrophoresis conditions were 2 V/cm for 2 min and 100 mA. Staining was done by ethidium bromide (20 lg/ml at 4°C, Sigma). The observation was with the samples still humid, the DNA fragment migration patterns of 100 cells for each dose level were evaluated with a fluorescence microscope (with excitation filter 420-490 nm [issue 510 nm]). The comets tails lengths were measured from the middle of the nucleus to the end of the tail with 40x increase for the count and measure the size of the comet. For visualization of DNA damage, observations are made of ethidium bromide-stained DNA using a 40x objective on a fluorescent microscope using public domain software for image analysis based on comet 5 image analysis software developed by Kinetic Imaging, Ltd. (Liverpool, UK) linked to a CCD camera. DNA damage was measured as tail length (TL = distance of DNA migration from the center of the body of the nuclear core), and tail intensity DNA (TI =% of genomic DNA that migrated during the electrophoresis from the nuclear core to the tail). By presenting all 3 parameters together, more information on the extent of the DNA damage can be obtained.
DNA fragmentation (Ladder) assay
In DNA laddering assay, low molecular weight fragments of oligo-nucleosomal DNA are extracted selectively from the cells whereas the higher molecular weight DNA stays associated with the nuclei. The isolated DNA is separated by electrophoresis and visualized using ethidium bromide. Briefly, 5x10 6 cells were resuspended in 500 ll Tris-EDTA buffer and lysed with 0.2% Triton X-100. DNA was precipitated in ethanol for 6 h in the presence of 0.5 M NaCl. The high molecular weight fraction was sediment by high-speed centrifugation, and the fragmented DNA was extracted from the aqueous phase with phenol and chloroform and then precipitated with isopropanol. After resuspension in Tris-EDTA buffer, the samples were incubated with RNase A (0.1 mg/ml) for 30 min at 37°C. Finally, DNA was electrophoresed using 2% agarose gel and visualized by ultraviolet light following ethidium bromide staining (Mariarosaria et al., 2003) .
Statistical analyses
Computer SPSS program version 17 was used. The results were expressed by applying Chi-square test and P values. P value < 0.05 was considered to be significant.
Results
Separation and characterization of camel IgG fractions
The IgG was successfully fractionated into its various subclasses by using PG and PA affinity chromatography as described by Shaker (2010) . PG affinity chromatography allowed the isolation of one HcAb subclass (fraction, camel IgG3) and the conventional antibody subclass IgG1 fraction. PA chromatography results revealed the presence of another HcAb subclass fraction corresponding to camel IgG2. The eluted fractions from PA and PG chromatography were analyzed by 12% SDS-PAGE with reducing agent. Protein bands were visualized after staining with 0.1% Coomassie Blue R250. Fraction IgG1, upon reduction, yielded two bands, 50 kDa heavy chains and 30 kDa light chains. The two other immunoglobulin fractions, upon reduction, yielded only heavy chains of 46 kDa (IgG2 fraction binding only to PA) and 43 kDa (IgG3 fraction binding to PG). These IgG2 and IgG3 subclasses appeared to lack the light chain completely.
The Comet DNA assay (SCGE)
Figs. 1-4 summarize the results of the comet assay of the three purified IgG subclasses at different concentrations (0.1, 0.01 and 0.001ug/ml) on the cell lines HCT116 and HepG2. It could be easily noticed in Fig. 1 , that tail length as marker for DNA fragmentation was increased at all concentrations tested by IgG subclasses on HCT116 cell lines and it was clearly obvious and potent with IgG2 and IgG3 fractions (nanobodies) than IgG1 (conventional antibody), while all IgG subclasses have Figure 1 Changes of tail length (lm) induced with different concentrations of IgG subclasses on HCT116 cell lines. no effect on HepG2 cell lines (Fig. 2) . These results were ascertained with the tail moment which shows same pattern of changes (Fig. 3) . Visualization of the DNA damage by using a 40· objective lens on a fluorescent microscope has been shown in Fig. 4 , using public domain software (Fig. 4B shows DNA damage and increased tail length while Fig. 4A shows control intact cells).
3.3. DNA fragmentation assay (DNA laddering assay) Fig. 5a , b and c reveals the results of DNA fragmentation assay. Formation of fragmented DNA, one of the typical apoptotic characters, was detected by the DNA ladder assay. It was observed by treating both cell lines (HepG2 and HCT116) with IgG subclasses (Fig. 5a) . A DNA laddering, due to multiple DNA fragments, was detected only in the supernatant fraction of HCT116 cell lines treated with IgG subclasses fractions, IgG1 (lanes 10 and 11), IgG2 (lanes 12 and 13) and IgG3 (lanes 14 and 15) . The DNA fragmentation is very typical of apoptotic process with generation within the nucleus of a series of multiples of a 180-200 bp subunit. Figs. 5b and 5c detect DNA fragmentation assay results versus the number of fragmented bands and percentage of compact DNA in the nucleus respectively.
Discussion
Despite significant advances in understanding the molecular aspects of cancer, conventional therapies have not changed dramatically within the past 25 years. The toxicities and adverse side effects of these therapies and the frequent emergence of resistance in recurrent tumors have led to a considerable increase in the clinical testing of monoclonal antibodies as singleagent anticancer therapies or as facilitators of tumor cell death in combination with existing therapies or search for alternative delivery of nonconventional therapy. Antibodies realizing their potential as anticancer therapeutics are still amenable for improvement in terms of functionality (e.g., stability, affinity, specificity and size) and pharmacokinetic properties (Carter, 2001) . Reducing the size of the conventional antibody to a Fab or scFv by cloning the corresponding gene fragments and expression in bacteria is becoming a standard technique Whitlow et al., 1993) . The discovery of functional heavy-chain antibodies in camelids creates a new opportunity to obtain soluble antigen-binding fragments of minimal size. These antibodies can be affinity-matured in vivo to yield molecules that interact via one variable domain with the antigen with adequate affinity and specificity. This variable fragment of 15 kDa with a typical immunoglobulin fold is called a nanobody (Vu et al., 1997) .
Poor tissue penetration is a serious obstacle to the successful development of antibody therapeutics in particular for immunotherapy of solid tumors (Beckman et al., 2007) . Antibodies and other anticancer agents have to overcome several barriers to reach their binding sites on the tumor cell. These barriers include systemic clearance, transport across the vasculature, limited convective flow and high interstitial pressure gradients. The rate of diffusion is a function of size and is approximately inversely proportional to molecular weight so a monovalent nanobody would be expected to saturate a tumor 10 times faster than a full-length IgG (Joost and Debbie, 2010) . The easy generation and manufacturing yield of nanobody-based conjugates together with their potent antitumor activity make nanobodies promising vehicles for new generation cancer therapeutics (Virna et al., 2004) .
The purpose of this study was to evaluate apoptotic effect of nanobodies as antitumor activity against HCT116 and HepG2 cell lines. We described the isolation of IgG subclasses (IgG1, IgG2 and IgG3) from the immunized camel serum using combination of affinity chromatography on PG and PA columns. The successful separation of the target nanobodies was ascertained by SDS-PAGE electrophoresis and was supported by the work of Daley et al. (2005) , who used the same columns to purify llama IgG isotype. Comet assay and nuclear staining were used for the assessment of apoptotic effect of purified IgG subclasses.
Several investigators have concluded that based on the characteristic appearance of the comets, apoptotic cells can be readily distinguished from necrotic cells in the alkaline SCG assay (Olive et al., 1993) . Apoptotic cells were concluded to form comets with large fan-like tails and small heads (called hedgehogs), while necrotic cells were concluded to form comets with relatively large heads and narrow tails of varying lengths (i.e., comets indistinguishable from those resulting from genotoxic damage).
The alkaline comets have a broader and more fragmented appearance and the tails are distinctly separated from the head. Practically the entire tail moves in the direction of a changed electric field. The single strands in partially double stranded DNA will easily entangle with other DNA molecules in the lysed nucleus, which will inhibit their possibility to escape from the head of the comet into the gel. The forked structure at the ends and the fact that partially single stranded fragments are bigger in size than the single stranded ones may inhibit the speed in the gel.
We have thus two types of molecules with widely different travelling speeds. The tail and head are therefore clearly sepa- rated by a waist in alkaline gels, in contrast to the continuous head and tail in neutral gels. As shown by the pictures the clearly obvious changes of tail length were demonstrated with different concentrations of IgG subclasses on HCT116 cell lines. It was clear that the tail length as marker for DNA fragmentation was increased at all concentrations used by IgG subclasses but it was potent with IgG2 and IgG3 fractions (nanobodies) than IgG1(conventional antibody). While all IgG subclasses have no effect on HepG2 cell line as compared with control culture. The best way to quantify the amount of DNA damage using digital comet image is by combining tail length and distribution of DNA in the tail (tail moment). Values for calculated tail moments for apoptotic cells are extremely high due to the large fraction of DNA in the tail and the pronounced distance of migration during electrophoresis. A certain fraction of cells is undamaged and thus retain low tail moments. A tail moment of greater than about 110 is indicative of apoptosis (Benjamin et al., 1997) . This was achieved in our study with IgG2 and IgG3 fractions (nanobodies). To confirm the apoptotic effect of the comet results, we further examined the apoptotic response, as judged by the appearance of a DNA ladder through agarose gel electrophoresis. DNA Laddering is a characteristic pattern of DNA fragmentation, which is the hallmark of apoptosis. DNA fragmentation is one of the later stages of apoptosis (Saraste and Pulkki, 2000) . Visual inspection of our images supports the findings of the comet assay which revealed that, IgG subclasses induced massive apoptosis only in the case of cancer colon. These finding may be explained by high expression of tumor antigens such as carcinoembryonic antigen (CEA) on cancer cells of epithelial origin (colorectal carcinoma) (Pragnesh et al., 2010) , where they are not expressed in other cells of the body except for low-level expression in gastrointestinal tissue. This is in agreement with the study of Cortez-Retamozo et al. (2004) , who revealed that, in oncology, HcAbs directed against CEA was used for targeting the genetically fused b-lactamase to tumor cells. This enzyme then converts an injected nontoxic prodrug into a toxic drug in the vicinity of the targeted tumor cells, leading to their killing.
Conclusion
We propose that nanobodies warrant further investigation as alternatives to conventional antibodies for therapeutic applications because of (1) their potentially better tumor penetration; (2) their potentially higher production yield due to a simpler two-chain molecular structure; (3) their lower dose requirements due to lower molecular weight and (4) versatility (Andrea et al., 2010) . Many of these inherent biophysical characteristics of nanobodies distinguish them from conventional antibodies and imbue them with several properties which make them well suited for drug development.
Massive fragmentation of cellular DNA makes apoptotic cells easy to distinguish using the comet assay, as almost the entire volume of DNA migrates outside the head of the comet. Comet test has many advantages, cell/cell approach, applicable on many cell types, no in vitro cultivation step required, cheap, fast, simplicity, and give indication on apoptosis. Overall our results demonstrated in the present in vitro study that nanobodies effectively induce more apoptosis on cancer colon than conventional antibodies, while both types have no apoptotic effect on hepatocellular carcinoma. Nanobodies might soon have reached a level of maturity that positions it as a highly robust and effective next generation biologics platform.
